Epithalon and anti-aging As telomeres shorten with age and epithalon induces telomerase activity and elongates telomeres, there is strong research interest in epithalon from an anti-aging standpoint: A 2003 study by Khavinson et al
FOXO4-DRI vs nearby senolytics Option FOXO4-DRI Type D-retro-inverso peptide Human trial stage None (preclinical only) Option Dasatinib + Quercetin (D+Q) Type Small-molecule drug + flavonoid Human trial stage Early human trials (e.g., Alzheimer's) Option Navitoclax Type BCL-2 family inhibitor Human trial stage Later-stage trials (e.g., myelofibrosis) D+Q and navitoclax are further along in humans but can affect healthy cells (e.g., low platelets)
Additionally, it plays a key role in nerve function and the production of DNA and red blood cells
Su L, Zhang B, Huang Y, Fan Z, Zhao Y
per-serving dose: Some brands list 500mg on the front but require you to take 2-3 capsules to reach that amount
That can mean fewer doses to reach the same effect